Skip to main content
. 2019 Sep 2;11(9):454. doi: 10.3390/pharmaceutics11090454

Figure 5.

Figure 5

(A) Expression of 12 kinases, 5 CCNs and 4 final GPCRs from Table 2, Table 3 and Table 4 in 44 ovarian cancer cell lines (B) 4 final GPCRs clustered against 44 ovarian cancer cell lines.